Literature DB >> 2703961

Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.

M C Ritz1, M J Kuhar.   

Abstract

Amphetamine and cocaine, commonly abused psychostimulants, often produce similar physiologic and behavioral effects in both animals and humans. We have shown previously that the reinforcing effects of cocaine can be correlated with drug binding to the mazindol and GBR 12935 binding sites on the dopamine transporter. In an attempt to identify the receptors associated with the reinforcing properties of amphetamine and related phenylethylamines, we have compared the potencies of these compounds in studies of drug reinforced behavior with their binding potencies at monoaminergic uptake sites and neurotransmitter receptor sites. The results of these experiments indicate that d-amphetamine exhibits a pharmacologically relevant micromolar affinity for dopamine, norepinephrine and serotonin uptake sites as well as for alpha-2 adrenergic receptor sites. Analysis of the data indicates that the reinforcing effects of phenylethylamines were not positively correlated with inhibition of ligand binding to any of the monoamine sites tested. However, the self-administration of amphetamine and related compounds may be inversely related to the inhibition of [3H]paroxetine binding to the serotonin transporter, suggesting that serotonin uptake inhibition opposes the reinforcing effects of amphetamine. This effect is not related to direct effects of drug binding at 5-HT2 receptor sites. Finally, amphetamine binding to alpha-2 adrenergic receptors suggests that these receptors could play a role in mediating the releasing or uptake inhibiting properties of the drug, and perhaps a role in some of its psychotomimetic effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703961

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  52 in total

Review 1.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

2.  Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.

Authors:  Chunyang Jin; Hernán A Navarro; F Ivy Carroll
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  J Pharmacol Exp Ther       Date:  2014-02-24       Impact factor: 4.030

4.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

5.  Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.

Authors:  Sevil Yasar; Jozsef Gaal; Zuzana Justinova; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

6.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 7.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

8.  Dopamine transporter-related effects of modafinil in rhesus monkeys.

Authors:  Monica L Andersen; Eileen Kessler; Kevin S Murnane; Jessica C McClung; Sergio Tufik; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

Review 9.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

10.  D1/D5 modulation of synaptic NMDA receptor currents.

Authors:  Juan A Varela; Silke J Hirsch; David Chapman; Leah S Leverich; Robert W Greene
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.